Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_provenance.
- NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_assertion description "[In familial cutaneous malignant melanoma (CMM), disruption of the retinoblastoma (pRB) pathway frequently occurs through inactivating mutations in the p16 (p16INK4A/CDKN2A/MTS1) gene or activating mutations in the G1-specific cyclin dependent kinase 4 gene (CDK4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_provenance.
- NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_assertion evidence source_evidence_literature NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_provenance.
- NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_assertion SIO_000772 10732752 NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_provenance.
- NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_assertion wasDerivedFrom befree-2016 NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_provenance.
- NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_assertion wasGeneratedBy ECO_0000203 NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_provenance.
- befree-2016 importedOn "2016-02-19" NP278864.RAcAM8lK40kzImkL8MOi-5S-U2JGQZ5V9S2aJ_n4L78ps130_provenance.